Replies to post #253109 on Avid Bioservices Inc (CDMO)

[JJ1223]

JJ1223, remember Bavi is not a monotherapy. Even if Bavi performs near the top of our grand expectations, other chemo and immune drugs will continue to sell. Bavi is not a solo act.

No one suggested it was. In combination with a drug from a top tier BP will cause fear and concern to all in the lung cancer fight. The first Bavi approval will cause a major rush to have it tested and included for many different indications in the IO and viral space.

Being wrong about the future causes doubt and leads to a change in CEO's. That fear is practiced everyday, and PS targeting is here to stay. Those who realize it will win, and those who don't will wish they had. Investors who realize it are fearful of selling their PPHM shares even though the share price stinks at these levels.